Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
India
/
Materials
Create a narrative
Anupam Rasayan India
NSEI:ANURAS Community
1
Narratives
written by author
0
Comments
on narratives written by author
2
Fair Values set
on narratives written by author
Create a narrative
Anupam Rasayan India
Popular
Undervalued
Overvalued
Anupam Rasayan India
WA
Analyst Price Target
Consensus Narrative from 8 Analysts
Expanding Pharma And Polymer Segments To Drive Future Success
Key Takeaways Pharma and Polymer growth, energy cost cuts, and a robust pipeline with new molecules will drive future revenue growth and improve net margins. Strengthened fluorination chemistry portfolio targets Japan and U.S. partnerships, boosting international sales and earnings significantly.
View narrative
₹717.13
FV
9.9% overvalued
intrinsic discount
29.44%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Your Valuation for
ANURAS
Anupam Rasayan India
Your Fair Value
₹
Current Price
₹788.10
41.8% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
44b
2015
2018
2021
2024
2025
2027
2030
Revenue ₹44.1b
Earnings ₹2.6b
Advanced
Set as Fair Value